Assura (LON:AGR) Earns “Hold” Rating from Peel Hunt

Peel Hunt restated their hold rating on shares of Assura (LON:AGR) in a research report report published on Tuesday, ThisIsMoney.Co.Uk reports.

Separately, Liberum Capital reaffirmed a hold rating on shares of Assura in a research report on Tuesday, July 2nd.

Assura stock opened at GBX 73.90 ($0.97) on Tuesday. The stock’s 50 day simple moving average is GBX 71.28 and its two-hundred day simple moving average is GBX 64.81. The company has a debt-to-equity ratio of 53.61, a quick ratio of 0.39 and a current ratio of 0.73. The stock has a market cap of $1.78 billion and a price-to-earnings ratio of 21.11. Assura has a fifty-two week low of GBX 52.40 ($0.68) and a fifty-two week high of GBX 75.60 ($0.99).

The company also recently disclosed a dividend, which was paid on Wednesday, October 16th. Shareholders of record on Thursday, September 12th were given a dividend of GBX 0.69 ($0.01) per share. The ex-dividend date was Thursday, September 12th. This represents a yield of 0.97%. Assura’s payout ratio is 0.86%.

In other Assura news, insider Jonathan Murphy sold 102,907 shares of Assura stock in a transaction that occurred on Tuesday, August 13th. The stock was sold at an average price of GBX 65 ($0.85), for a total transaction of £66,889.55 ($87,403.04). Also, insider Orla Ball sold 9,733 shares of Assura stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of GBX 71 ($0.93), for a total value of £6,910.43 ($9,029.70).

About Assura

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high-quality patient care in the community.

Recommended Story: Cost of Equity

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit